Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Cabergoline or its saltsPDL I DEC / 13
CalcipotriolPDL I DEC / 13
CalcitoninPDL I DEC / 13
CalcitriolPDL I DEC / 13
Calcium bromidePDL I DEC / 13
Calcium bromolactobionatePDL I DEC / 13
Calcium carbimidePDL I DEC / 13
Calcium chloride in injectable form for parenteral nutrition I JAN / 03
Calcium disodium edetate II SEP / 98
Calcium gluconate in injectable form for parenteral nutrition I JAN / 03
Calcium polycarbophil III SEP / 98
Calcium salts when sold for the treatment of hyperphosphatemiaPDL I DEC / 13
CalusteroneC3 I JUN / 02
CamazepamTS I JUN / 02
Camphor in oleaginous vehicles and in liquid forms in concentrations greater than 11% II OCT / 98
Camphor. in oleaginous vehicles and in liquid forms in concentrations up to and including 11% U OCT / 98
CanagliflozinPDL I JUL / 14
CanakinumabPDL I DEC / 13
Candesartan or its salts or derivatives

including but not limited to candesartan cilexetil

I DEC / 13
Candicidin or its salts or derivativesPDL I DEC / 13
CannabisN

its preparations and derivatives, as listed in the schedules to the Controlled Drugs and Substances Act and the Narcotic Control Regulations

I JUL / 15
Cantharides, their preparations and derivatives II SEP / 98
Capreomycin or its salts ir deriviativesPDL I DEC / 13
Caprylic acid except when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.0 for a use other than to be applied to warts, corns or calluses U DEC / 14
Capsaicin U AUG / 97
Captodiamine or its saltsPDL I DEC / 13
Captopril or its saltsPDL I DEC / 13
CarbacholPDL I DEC / 13
CarbamazepinePDL I DEC / 13
Carbenoxolone or its saltsPDL I DEC / 13
Carbetocin or its saltsPDL I DEC / 13
Carbidopa or its saltsPDL I DEC / 13
CarbimazolePDL I DEC / 13
Carbinoxamine or its salts III SEP / 98
CarbocisteinePDL I DEC / 13
Carbomycin or its salts or derivativesPDL I DEC / 13
CarboplatinPDL I DEC / 13
CarbromalPDL I DEC / 13
CarfentanilN I JUN / 02
CarfilzomibPDL I AUG / 16
Carglumic acid or its salts or derivativesPDL I JUN / 15
CarisoprodolPDL I DEC / 13
CarmustinePDL I DEC / 13
Carphenazine or its saltsPDL I DEC / 13
Carprofen or its salts or derivativesPDL I DEC / 13
Carvedilol and its saltsPDL I DEC / 13
Casanthranol III SEP / 98
Cascara sagrada or its extracts or derivatives U AUG / 97
Caspofungin or its salts or derivativesPDL I DEC / 13
CatumaxomabPDL I DEC / 13
Celecoxib or its saltsPDL I DEC / 13
Cephalosporin C or its salts or derivativesPDL

including but not limited to: cefdinir, cefepime, cefonicide, cefoperazone, cefpodoxime proxetil, cefprozil, ceftazidime, ceftibuten, ceftolozane, cefuroxime, lorcarbef.

I APR / 17
Cerapon III SEP / 98
Ceritinib or its saltsPDL I MAY / 15
Cerivastatin or its saltsPDL I DEC / 13
Certolizumab pegolPDL I DEC / 13
Cetirizine or its saltsPDL

see hydroxyzine or its salts or derivatives

I DEC / 13
Cetirizine or its salts. in concentrations of 10 mg equivalent to 8.5 mg or less of cetirizine base per dosage unit, in products marketed for pediatric use (under 12 years of age) III JUL / 02
Cetirizine or its salts..

in concentrations of 10mg equivalent to 8.5mg or less of cetirizine base per dosage unit) in products marketed for adult use (age 12 and over)

U JUL / 02
Cetrorelix or its saltsPDL I DEC / 13
CetuximabPDL I DEC / 13
Charcoal (activated) except for use in poisoning treatment U JUN / 98
Charcoal [activated] for use in poisoning treatment II SEP / 98
Chlophedianol and its salts III SEP / 98
ChloralPDL I DEC / 13
Chloral hydratePDL I DEC / 13
ChloralformamidePDL I DEC / 13
ChloralimidePDL I DEC / 13
Chlorambucil or its salts or derivativesPDL I DEC / 13
Chloramphenicol or its salts or derivativesPDL I DEC / 13
Chlorcyclizine or its saltsPDL

except in preparations for external use

I DEC / 13
Chlordiazepoxide and its saltsTS I SEP / 98
Chlorhexidine or its saltsPDL

for human use when used as a topical oral preparation

I DEC / 13
Chlorisondamine or its saltsPDL I DEC / 13
ChlormezanonePDL I DEC / 13
Chloroprocaine and its salts for parenteral or ophthalmic use II SEP / 98
Chloroprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Chloroquine or its saltsPDL I DEC / 13
Chlorothiazide or its salts or derivatives

for human use

I DEC / 13
Chlorpheniramine and its salts and preparations U AUG / 97
Chlorphentermine and any salt thereofC2 I JUN / 02
Chlorpromazine or its saltsPDL

for human use

I DEC / 13
ChlorpropamidePDL I DEC / 13
Chlorprothixene or its saltsPDL I DEC / 13
Chlorzoxazone and its salts III SEP / 98
Cholecystokinin II SEP / 98
Cholera vaccine except oral, inactivated, when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) I JAN / 04
Cholera vaccine (oral, inactivated) when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) II JAN / 04
Cholestyramine resinPDL

for human use

I DEC / 13
Choline bitartrate parenteral II SEP / 98
Choline salicylatePDL

when sold in combination with magnesium salicylate

I DEC / 13
Choline theophyllinatePDL I DEC / 13
Choriogonadotropin alfaPDL I DEC / 13
Chromium Chloride (chromic chloride) in injectable form for parenteral nutrition I JAN / 03
Chymopapain parenteral II SEP / 98
Chymotrypsin parenteral and ophthalmic II SEP / 98
Ciclopirox or its saltsPDL I DEC / 13
Cilastatin or its saltsPDL I DEC / 13
Cilazapril or its salts or derivativesPDL I DEC / 13
Cimetidine or its saltsPDL

for veterinary use

I DEC / 13

177 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled